Surgical Management of Intrahepatic Cholangiocarcinoma: From Technical Resectability to Biological Decision – Making
Kosova Journal of Surgery · 15.08.2026 · 10 (2) · 76-87
DOI: 10.59928/ypwtn695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kosova Journal of Surgery, online erschienen am 15.08.2026. Verfasst von José M. Ramia und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intrahepatic cholangiocarcinoma (ICC) remains one of the most challenging malignancies in hepatobiliary surgery. Although surgical resection offers the only potential for cure, up to half of patients are unresectable at diagnosis, and long-term survival remains poor. More importantly, contemporary surgical decision-making has evolved beyond technical resectability toward identifying patients most likely to derive meaningful oncological benefit from surgery. This narrative review examines the major clinical decisions that define modern surgical management of ICC, including patient selection, preoperative staging, extent of hepatic resection, lymphadenectomy, resection margins, and minimally invasive surgery. Rather than reviewing these topics independently, the available evidence is interpreted through the emerging concept of futile resection and its relationship with tumor biology. Current international evidence is integrated with our experience from the Spanish multicenter ICC registry (SPAIC), including studies on surgical complexity, futility, minimally invasive surgery, and failure to rescue. Across the available literature, biological factors—particularly lymph node metastases, multifocal disease, and advanced T stage—consistently outweigh technical aspects of surgery in determining long-term outcome. Complexity classifications and futility prediction models should therefore be considered complementary tools: the former guiding how surgery should be performed, the latter helping determine whether surgery should be performed at all. Future progress in ICC surgery will depend on integrating imaging, biomarkers, operative complexity, and tumor biology into individualized multidisciplinary decision-making, allowing surgeons to select not only technically resectable patients, but those most likely to benefit from resection.
Zitieren
APA
Ramia, J. M., Villodre-Tudela, C., Melgar-Requena, P., Rubio, J. J., Franco-Campello, M., & Alcázar-López, C. F. (2026). Surgical Management of Intrahepatic Cholangiocarcinoma: From Technical Resectability to Biological Decision – Making. Kosova Journal of Surgery, 10(2), 76-87. https://doi.org/10.59928/ypwtn695
Vancouver
Ramia JM, Villodre-Tudela C, Melgar-Requena P, Rubio JJ, Franco-Campello M, Alcázar-López CF. Surgical Management of Intrahepatic Cholangiocarcinoma: From Technical Resectability to Biological Decision – Making. Kosova Journal of Surgery. 2026;10(2):76-87. doi:10.59928/ypwtn695
BibTeX
@article{Ramia2026,
author = {Ramia, José M. and Villodre-Tudela, Celia and Melgar-Requena, Paola and Rubio, Juan Jesús and Franco-Campello, Mariano and Alcázar-López, Cándido F.},
title = {Surgical Management of Intrahepatic Cholangiocarcinoma: From Technical Resectability to Biological Decision – Making},
journal = {Kosova Journal of Surgery},
year = {2026},
volume = {10},
number = {2},
pages = {76--87},
doi = {10.59928/ypwtn695}
}
EUVIMED